Integrating Advanced Computational and Artificial Intelligence-based Methodologies for the Discovery of Ubiquitin Specific Protease 21 (USP21) Inhibitors as Lung Cancer Therapeutics: An FDA-approved and Investigational Drug Repurposing Study - KIVIRID

Integrating Advanced Computational and Artificial Intelligence-based Methodologies for the Discovery of Ubiquitin Specific Protease 21 (USP21) Inhibitors as Lung Cancer Therapeutics: An FDA-approved and Investigational Drug Repurposing Study

Authors: T. Kanan, D. Kanan, M. Kandula

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a5508

Source: Full article

Abstract

No abstract found.